Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 23 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.79 Insider Own29.71% Shs Outstand127.46M Perf Week-12.46%
Market Cap773.96M Forward P/E- EPS next Y-2.83 Insider Trans-0.05% Shs Float92.21M Perf Month-24.26%
Income-341.97M PEG- EPS next Q-0.74 Inst Own71.73% Short Float12.12% Perf Quarter-41.00%
Sales25.55M P/S30.29 EPS this Y-3.44% Inst Trans1.50% Short Ratio9.43 Perf Half Y-12.85%
Book/sh5.90 P/B1.00 EPS next Y1.78% ROA-35.19% Short Interest11.17M Perf Year-53.69%
Cash/sh5.72 P/C1.03 EPS next 5Y- ROE-40.18% 52W Range5.78 - 13.32 Perf YTD-46.41%
Dividend Est.- P/FCF- EPS past 5Y-38.74% ROI-42.72% 52W High-55.71% Beta1.72
Dividend TTM- Quick Ratio25.44 Sales past 5Y319.82% Gross Margin79.38% 52W Low2.08% ATR (14)0.43
Dividend Ex-Date- Current Ratio25.44 EPS Y/Y TTM-7.58% Oper. Margin-1485.19% RSI (14)26.19 Volatility6.25% 5.67%
Employees323 Debt/Eq0.07 Sales Y/Y TTM1749.89% Profit Margin-1338.60% Recom1.33 Target Price23.05
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q-19.95% Payout- Rel Volume0.67 Prev Close5.95
Sales Surprise-100.69% EPS Surprise6.71% Sales Q/Q-100.00% EarningsFeb 22 AMC Avg Volume1.18M Price5.90
SMA20-16.63% SMA50-30.90% SMA200-37.16% Trades Volume798,408 Change-0.84%
Date Action Analyst Rating Change Price Target Change
Apr-20-23Upgrade Jefferies Underperform → Hold $12.50
Apr-19-23Upgrade Raymond James Outperform → Strong Buy $29
Apr-13-23Initiated Raymond James Outperform $29
Feb-03-23Initiated Oppenheimer Outperform $33
Sep-30-22Initiated Barclays Equal Weight $23
Sep-02-22Initiated Stifel Buy $40
Jun-06-22Initiated Jefferies Underperform $13
Feb-01-22Initiated Berenberg Buy $45
Jul-21-21Initiated BofA Securities Buy $50
Dec-15-20Reiterated H.C. Wainwright Buy $54 → $57
Apr-11-24 04:05PM
Mar-17-24 05:20PM
Mar-15-24 12:39PM
Mar-13-24 09:55AM
Feb-26-24 04:05PM
09:55AM Loading…
Feb-22-24 04:40PM
Feb-15-24 04:05PM
Feb-01-24 04:05PM
Jan-18-24 05:37AM
Jan-08-24 07:00AM
Jan-02-24 04:05PM
09:55AM Loading…
Nov-30-23 09:55AM
Nov-14-23 09:55AM
Nov-07-23 04:05PM
Nov-02-23 06:21PM
Oct-31-23 12:00PM
Oct-26-23 04:05PM
Oct-12-23 04:05PM
Sep-18-23 04:05PM
Aug-31-23 10:16PM
Aug-08-23 06:05PM
Aug-01-23 04:05PM
May-25-23 05:01PM
04:05PM Loading…
May-24-23 04:05PM
May-18-23 08:16AM
May-04-23 07:25PM
Apr-27-23 04:05PM
Apr-21-23 02:48PM
Apr-20-23 02:20AM
Apr-19-23 07:30AM
Apr-18-23 10:40AM
Apr-14-23 05:05AM
Apr-13-23 06:12PM
Apr-07-23 07:44AM
Apr-06-23 09:55AM
Mar-06-23 07:30AM
Mar-01-23 07:30AM
Feb-25-23 07:31AM
Feb-23-23 05:45PM
Feb-21-23 10:00AM
Feb-16-23 04:05PM
Feb-07-23 05:01PM
Feb-02-23 07:30AM
Jan-13-23 11:11AM
Jan-03-23 07:30AM
Dec-31-22 08:53AM
Nov-24-22 08:02AM
Nov-17-22 01:58PM
Nov-07-22 07:30AM
Nov-03-22 06:35PM
Oct-27-22 04:05PM
Oct-14-22 10:14AM
Sep-26-22 07:30AM
Sep-23-22 07:30AM
Sep-12-22 09:30PM
Sep-11-22 09:45AM
Sep-08-22 04:06PM
Aug-30-22 11:15AM
Aug-25-22 02:48PM
Aug-18-22 04:05PM
Aug-04-22 04:05PM
Jul-28-22 04:05PM
Jun-27-22 06:00AM
Jun-16-22 07:30AM
May-26-22 07:30AM
May-07-22 09:59AM
May-05-22 04:05PM
May-03-22 07:30AM
Apr-28-22 04:05PM
Feb-24-22 04:05PM
Feb-17-22 04:05PM
Feb-10-22 11:51AM
Feb-02-22 07:30AM
Jan-04-22 07:30AM
Jan-03-22 07:30AM
Dec-22-21 11:11AM
Dec-18-21 12:38AM
Dec-10-21 07:30AM
Nov-17-21 11:39AM
Nov-16-21 12:36PM
Nov-10-21 04:05PM
Nov-04-21 04:05PM
Oct-27-21 01:23PM
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bergstrom Donald APresident, R&DMar 27 '24Sale7.707655,890530,113Mar 29 04:15 PM
Catinazzo ThomasChief Financial OfficerMar 27 '24Sale7.703482,680341,498Mar 29 04:15 PM
Adams BrianChief Legal OfficerMar 27 '24Sale7.703482,680327,390Mar 29 04:15 PM
Rahmer PeterSee remarksMar 27 '24Sale7.702982,295514,679Mar 29 04:15 PM
Bergstrom Donald APresident, R&DJan 29 '24Sale9.643,17830,636530,878Jan 31 04:08 PM
Catinazzo ThomasChief Financial OfficerJan 29 '24Sale9.642,00519,328341,846Jan 31 04:11 PM
Adams BrianChief Legal OfficerJan 29 '24Sale9.641,92918,596327,738Jan 31 04:05 PM
Rahmer PeterSee remarksJan 29 '24Sale9.641,65115,916514,977Jan 31 04:14 PM
Bergstrom Donald APresident, R&DDec 27 '23Sale11.5197711,245234,056Dec 29 04:17 PM
Catinazzo ThomasChief Financial OfficerDec 27 '23Sale11.512943,384143,851Dec 29 04:22 PM
Adams BrianChief Legal OfficerDec 27 '23Sale11.512943,384129,667Dec 29 04:14 PM
Rahmer PeterSee remarksDec 27 '23Sale11.512442,808316,628Dec 29 04:26 PM
Bergstrom Donald APresident, R&DOct 30 '23Sale6.033,45120,810235,033Nov 01 04:14 PM
Catinazzo ThomasChief Financial OfficerOct 30 '23Sale6.031,69710,233144,145Nov 01 04:18 PM
Adams BrianChief Legal OfficerOct 30 '23Sale6.031,6329,841129,961Nov 01 04:07 PM
Rahmer PeterSee remarksOct 30 '23Sale6.031,3548,165316,872Nov 01 04:21 PM
Bergstrom Donald APresident, R&DSep 27 '23Sale8.386485,430238,484Sep 29 04:52 PM
Catinazzo ThomasChief Financial OfficerSep 27 '23Sale8.382942,464145,842Sep 29 04:22 PM
Adams BrianChief Legal OfficerSep 27 '23Sale8.382942,464131,593Sep 29 04:10 PM
Rahmer PeterSee remarksSep 27 '23Sale8.382442,045318,226Sep 29 04:32 PM
Bergstrom Donald APresident, R&DJul 28 '23Sale11.802,68331,659237,904Jul 31 04:48 PM
Catinazzo ThomasChief Financial OfficerJul 28 '23Sale11.801,69319,977146,136Jul 31 04:50 PM
Adams BrianChief Legal OfficerJul 28 '23Sale11.801,62819,210131,887Jul 31 04:46 PM
Rahmer PeterSee remarksJul 28 '23Sale11.801,35215,954316,808Jul 31 04:52 PM
Bergstrom Donald APresident, R&DJun 27 '23Sale12.126477,842240,587Jun 28 05:06 PM
Adams BrianChief Legal OfficerJun 27 '23Sale12.122943,563133,515Jun 28 05:02 PM
Catinazzo ThomasChief Financial OfficerJun 27 '23Sale12.122943,563147,829Jun 28 05:08 PM
Rahmer PeterSee remarksJun 27 '23Sale12.122442,957318,160Jun 28 05:12 PM
Bergstrom Donald APresident, R&DApr 28 '23Sale11.161,38315,434242,701May 01 04:29 PM
Adams BrianChief Legal OfficerApr 28 '23Sale11.168639,631134,882May 01 04:26 PM
Catinazzo ThomasChief Financial OfficerApr 28 '23Sale11.168639,631149,272May 01 04:31 PM
Rahmer PeterSee remarksApr 28 '23Sale11.167398,247157,504May 01 04:33 PM